| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ALNYLAM PHARMACEUTICALS INC | 948,286 | 64,275,000 | 19.43% | ||
| 2 | AVEXIS INC COM | 825,980 | 34,039,000 | 10.29% | ||
| 3 | AGENUS INC | 4,141,644 | 29,737,000 | 8.99% | ||
| 4 | LA JOLLA PHARMACEUTICAL CO | 1,170,151 | 27,838,000 | 8.41% | ||
| 5 | BIOCRYST PHARMACEUTICALS | 4,204,579 | 18,542,000 | 5.60% | ||
| 6 | INCYTE | 191,151 | 18,024,000 | 5.45% | ||
| 7 | ACHILLION PHARMACEUTICALS INC COM | 2,208,749 | 17,891,000 | 5.41% | ||
| 8 | Dicerna Pharmaceuticals | 2,026,894 | 11,918,000 | 3.60% | ||
| 9 | BRISTOL MYERS SQUIBB CO | 209,701 | 11,307,000 | 3.42% | ||
| 10 | SPDR GOLD TR | 83,000 | 10,428,000 | 3.15% | ||
| 11 | Atara Biotherapeutics Inc. | 458,113 | 9,799,000 | 2.96% | ||
| 12 | ARROWHEAD PHARMACEUTICALS IN | 1,116,777 | 8,208,000 | 2.48% | ||
| 13 | HERON THERAPEUTICS INC | 386,787 | 6,664,000 | 2.01% | ||
| 14 | Viveve Medical Inc | 839,274 | 6,060,000 | 1.83% | ||
| 15 | BLUEBIRD BIO INCORPORATED | 87,734 | 5,947,000 | 1.80% | ||
| 16 | CORIUM INTERNATIONAL INC | 1,045,747 | 5,888,000 | 1.78% | ||
| 17 | INVUITY INC | 392,838 | 5,390,000 | 1.63% | ||
| 18 | CELLDEX THERAPEUTICS INC NEW | 1,243,164 | 5,022,000 | 1.52% | ||
| 19 | MEDICINES CO | 123,000 | 4,642,000 | 1.40% | ||
| 20 | OMEROS CORP | 383,012 | 4,274,000 | 1.29% | ||
| 21 | TACTILE SYS TECHNOLOGY INC | 227,599 | 4,256,000 | 1.29% | ||
| 22 | BARCLAYS BANK PLC | 180,500 | 4,018,000 | 1.21% | ||
| 23 | REGENXBIO INC COM | 238,740 | 3,345,000 | 1.01% | ||
| 24 | Oxford Immunotec Global PLC | 235,900 | 2,963,000 | 0.90% | ||
| 25 | FIVE PRIME THERAPEUTICS INC | 44,044 | 2,312,000 | 0.70% | ||
| 26 | GLOBAL BLOOD THERAPEUTICS IN COM | 95,714 | 2,206,000 | 0.67% | ||
| 27 | MASIMO CORP COM | 25,900 | 1,541,000 | 0.47% | ||
| 28 | NOVAVAX INC COM | 4,787 | 996,000 | 0.30% | Call | |
| 29 | MIRATI THERAPEUTICS INC COM | 129,129 | 854,000 | 0.26% | ||
| 30 | SENSUS HEATLHCARE INC | 125,700 | 773,000 | 0.23% | ||
| 31 | BIOPHARMX CORP COM | 700,636 | 389,000 | 0.12% | ||
| 32 | Audentes Therapeutics, Inc. | 20,000 | 356,000 | 0.11% | ||
| 33 | NATERA INC | 31,693 | 352,000 | 0.11% | ||
| 34 | MANNKIND CORPORATION | 4,385 | 272,000 | 0.08% | Put | |
| 35 | Nivalis Therapeutics Inc | 30,000 | 244,000 | 0.07% | ||
| 36 | ABEONA THERAPEUTICS INC | 19,391 | 116,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Restatement filing (0001493152-16-015263, filed 2016.11.18).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
